The medical device maker has been working to turn around the division over the last few years.
Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.
Medtronic (MDT) closed the most recent trading day at $84.25, moving -1.01% from the previous trading session.
In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.
Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent mid-single-digit organic revenue growth.
Medical device specialist Medtronic (MDT 1.38%) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow revenue growth.
Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.
Medtronic (MDT) concluded the recent trading session at $84.76, signifying a +0.19% move from its prior day's close.
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.
Medtronic (MDT) reachead $84.30 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.